Clinical Trial Update: Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation [NA]

View source ↗

Summary

A clinical trial investigating body composition in hepatocellular carcinoma patients treated with radioablation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Conditions: Liver Carcinoma | NA | Status: WITHDRAWN